Roche Holding AG (SWX:ROG)
257.60
-2.30 (-0.88%)
May 9, 2025, 5:36 PM CET
Revenue by Product
Fiscal year is January - December.
Year Ending | TTM | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
---|---|---|---|---|---|
Roche Pharmaceuticals | - |
Log In |
Log In |
Log In |
Log In |
Roche Pharmaceuticals Growth | - |
Log In |
Log In |
Log In |
Log In |
Chugai | - |
Log In |
Log In |
Log In |
Log In |
Chugai Growth | - |
Log In |
Log In |
Log In |
Log In |
Pharmaceuticals | 47.20B |
Log In |
Log In |
Log In |
Log In |
Pharmaceuticals Growth | 8.31% |
Log In |
Log In |
Log In |
Log In |
Diagnostics | 14.34B |
Log In |
Log In |
Log In |
Log In |
Diagnostics Growth | 0.86% |
Log In |
Log In |
Log In |
Log In |
Capex by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
---|---|---|---|---|
Roche Pharmaceuticals Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
Roche Pharmaceuticals Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
Chugai Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
Chugai Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
Pharmaceuticals Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
Pharmaceuticals Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
Diagnostics Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
Diagnostics Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
Corporate Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
Corporate Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
EBIT by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
---|---|---|---|---|
Roche Pharmaceuticals Operating Profit |
Log In |
Log In |
Log In |
Log In |
Roche Pharmaceuticals Operating Profit Growth |
Log In |
Log In |
Log In |
Log In |
Chugai Operating Profit |
Log In |
Log In |
Log In |
Log In |
Chugai Operating Profit Growth |
Log In |
Log In |
Log In |
Log In |
Pharmaceuticals Operating Profit |
Log In |
Log In |
Log In |
Log In |
Pharmaceuticals Operating Profit Growth |
Log In |
Log In |
Log In |
Log In |
Diagnostics Operating Profit |
Log In |
Log In |
Log In |
Log In |
Diagnostics Operating Profit Growth |
Log In |
Log In |
Log In |
Log In |
Corporate Operating Profit |
Log In |
Log In |
Log In |
Log In |
Corporate Operating Profit Growth |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
---|---|---|---|---|
Switzerland |
Log In |
Log In |
Log In |
Log In |
Switzerland Growth |
Log In |
Log In |
Log In |
Log In |
Germany |
Log In |
Log In |
Log In |
Log In |
Germany Growth |
Log In |
Log In |
Log In |
Log In |
Rest of Europe |
Log In |
Log In |
Log In |
Log In |
Rest of Europe Growth |
Log In |
Log In |
Log In |
Log In |
Europe |
Log In |
Log In |
Log In |
Log In |
Europe Growth |
Log In |
Log In |
Log In |
Log In |
United States |
Log In |
Log In |
Log In |
Log In |
United States Growth |
Log In |
Log In |
Log In |
Log In |
Rest of North America |
Log In |
Log In |
Log In |
Log In |
Rest of North America Growth |
Log In |
Log In |
Log In |
Log In |
North America |
Log In |
Log In |
Log In |
Log In |
North America Growth |
Log In |
Log In |
Log In |
Log In |
Latin America |
Log In |
Log In |
Log In |
Log In |
Latin America Growth |
Log In |
Log In |
Log In |
Log In |
Japan |
Log In |
Log In |
Log In |
Log In |
Japan Growth |
Log In |
Log In |
Log In |
Log In |
Rest of Asia |
Log In |
Log In |
Log In |
Log In |
Rest of Asia Growth |
Log In |
Log In |
Log In |
Log In |
Asia |
Log In |
Log In |
Log In |
Log In |
Asia Growth |
Log In |
Log In |
Log In |
Log In |
Africa, Australia and Oceania |
Log In |
Log In |
Log In |
Log In |
Africa, Australia and Oceania Growth |
Log In |
Log In |
Log In |
Log In |